Virtual Events
Virtual TypeOneNation Summit Now on Demand!
View recorded sessions from the September 26 event!
Speakers: T1D medical and scientific experts, ambassadors, social influencers and community members
The TypeOneNation Virtual Summit will remain open through the end of the year where you can view all of the sessions on demand when it’s most convenient for you. Visit as often as you’d like to catch up on sessions you missed, re-watch your favorites and download informational content at the virtual booths in the Exhibit Hall and JDRF Community Room. If you have a question for our sponsors and community partners, visit their virtual booth and click the envelope icon to send a direct email message.
Login or register to view sessions: https://jdrf.6connex.com/event/typeonenationsummit/login
T1D Functional Cure Being Tested in Humans: An Update from ViaCyte
Thursday, December 3rd | 5:00-6:00 p.m. PT
Speaker: Dr. Manasi Sinha Jaiman, Vice President of Clinical Development, ViaCyte
Dr. Manasi Sinha Jaiman will share an update on their product candidates and the current status and results from their human clinical trials. ViaCyte is a regenerative medicine company focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for type 1 diabetes. Advancing research in beta cell replacement is a core pillar of JDRF’s research strategy and JDRF has been a significant supporter of ViaCyte.
Registration Information: Register Here
COVID-19 & T1D: School & Employment Rights
Tuesday, December 8th | 6:00-7:00 p.m. ET
Speaker: Daniel Phelan, Chairman and Chief Executive Officer, Type 1 Action Foundation, Inc.
We know many of you continue to face decisions with evolving school models and job accommodations. Join us for a conversation with Daniel Phelan to learn more about school and employment rights during the COVID-19 pandemic.
Registration Information: JDRF Facebook Live
Cooking Demo with Bonnie Carlson
Monday, December 14th | 4:00-5:00 p.m. PT
Speaker: Bonnie Carlson co-wrote the cookbook “The Reset Factor Kitchen: 101 Tasty Recipes to Eat Your Way to Wellness, Burn Belly Fat, and Maximize Your Energy”
Bonnie will share some of her favorite recipes.
Registration Information: Join us on Twitch
Ask the Endo
Tuesday, December 15th | 8:00-9:00 a.m. PT
Speaker: Dr. Saleh Adi, semi-retired and former Director of the Madison Clinic for Pediatric Diabetes at UCSF Children’s Hospital and co-founder of Tidepool
Whether you have a question on type 1 diabetes (T1D) technology, carb counting, or Dr. Adi’s personal favorite – how to make sense of your CGM data – Dr. Adi is available to help answer your questions.
Registration Information: https://www.jdrf.org/norcal/events/ask-the-endo-2/
Thank You to Our Sponsors
Premier Sponsor
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Supporting Sponsors
Abbott, the worldwide leader in Continuous Glucose Monitoring, has put a focus on helping people with diabetes lead healthier happier lives. They are dedicated to developing the next generation technologies that will provide glucose readings faster, with less inconvenience and help patients take charge of their diabetes. Start a New Chapter in Managing Your Diabetes with a FreeStyle Libre 2 free trial!
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. Get Started Today
ERinfo understands the challenges, struggles and stress that comes with T1D. ERinfo offers anywhere, anytime identification and contact notifications during emergency situations. We provide medical first responders access to your information through a direct connection to FirstNet®, the government’s nationwide broadband network that equips responders to save lives and protect you throughout the US. We are working with JDRF to educate the T1D community on the importance of using medical alerts. Be Prepared – Enroll Today with a 15% JDRF Discount!
At Xeris, makers of the Gvoke HypoPen, we believe that easy-to-use medicines can have a profound impact on the lives of patients and their families. That’s why we’re studying ready-to-use liquid glucagon, but that’s just the beginning. Learn how our technology is unlocking the potential of today’s medicines.
For more than 30 years, Medtronic has been helping people with diabetes.
Medtronic is working with the global community to change the way people manage diabetes. Together, we will transform diabetes care by expanding access, integrating care and improving outcomes, so people with diabetes can enjoy greater freedom and better health.
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: rare bleeding disorders, growth hormone-related disorders, and obesity.
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform.
Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin.
Be the first to know about T1D news, local events and more.
By clicking Sign Up, I agree to the JDRF Privacy Policy. I also agree to receive emails from JDRF and I understand that I may opt out of JDRF subscriptions at any time.